4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050129
Options or other derivatives
- SVP, Drug Discovery acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| EMPFIELD JAMES R. SVP, Drug Discovery | 2019-09-16 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/doc4.xml…